Individualized Duration of Dual Antiplatelet Therapy Guided by Risk Scores - Ready for Prime Time?
Circ J
.
2020 Jan 24;84(2):153-155.
doi: 10.1253/circj.CJ-19-1149.
Epub 2020 Jan 15.
Authors
Sergio Buccheri
1
,
Stefan James
1
Affiliation
1
Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University.
PMID:
31941851
DOI:
10.1253/circj.CJ-19-1149
No abstract available
Publication types
Editorial
Comment
MeSH terms
Drug Therapy, Combination
Drug-Eluting Stents*
Dual Anti-Platelet Therapy
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Substances
Platelet Aggregation Inhibitors